Zhilong Dong
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer (NCT07424560) | Zhilong Dong | 2026-02-25 |
Track Zhilong Dong automatically
Every clearance here is in the API, with alerts when new ones post.